Melanoma Insights for Professionals

About Melanoma Insights for Professionals

Melanoma Insights for Professionals brings you conversations with leading multidisciplinary experts who break down the latest research and best practice into what it actually means in the clinic. Developed by Melanoma Institute Australia, this podcast helps healthcare professionals stay ahead of developments in melanoma and complex skin cancer—while uncovering the thinking behind expert clinical decision-making.

Publisher

Melanoma Institute Australia

Category

health & fitness

Language

en

Explicit

No

First episode

22 Mar 2019

Latest episode

18 Sept 2026

Latest episodes

39 episodes in the feed.

1. 

   18 Sept 2026

   The future of melanoma detection: Targeted screening, technology and the changing landscape

   How will melanoma detection change over the next decade? In this episode from MIA’s podcast Melanoma Insights for Professionals, our multidisciplinary experts explore how targeted screening, personalised risk assessment, advanced imaging, artificial intelligence and evolving models of care could transform the way melanoma is detected. The discussion provides insight into how we can identify those most likely to benefit from screening, reduce unnecessary biopsies and surveillance, and make better use of Australia’s limited healthcare workforce and resources. This podcast is suitable for dermatologists, skin cancer doctors, GPs, nurses, public health researchers and other healthcare professionals. LEARNING OBJECTIVES Identify key risk factors for melanoma and describe how risk stratification can be used to inform personalised prevention, skin checks and surveillance. Discuss the potential benefits, harms and limitations of targeted melanoma screening and emerging detection technologies, including imaging and artificial intelligence (AI). Discuss the implications of evolving melanoma detection strategies for general practice, including workforce requirements, models of care, triage and referral pathways. REFERENCES AND RESOURCES Yan S, Yu Z, Primiero C, Vico-Alonso C, et al. Amultimodal vision foundation model for clinical dermatology. (https://www.nature.com/articles/s41591-025-03747-y) Nat Med. 2025 Aug;31(8):2691-2702. Snoswell CL, Caffery LJ, Whitty JA, et al. Cost-effectiveness of Skin Cancer Referraland Consultation Using Teledermoscopy in Australia (https://jamanetwork.com/journals/jamadermatology/fullarticle/2680742). JAMA Dermatol. 2018;154(6):694–700. MIA's Melanoma Risk Prediction Calculators (https://www.melanomarisk.org.au/) More information on the Roadmap for a National Targeted Melanoma Screening Program. (https://melanoma.org.au/research/roadmap-targeted-melanoma-screening-program/) ACCREDITATION This podcast has been accredited for 0.5 EA CPD hours in the RACGP and SkinPro CPD Programs. To obtain a Certificate of Completion and have CPD hours uploaded on your behalf, please listen to this podcast via the Melanoma Education Portal (https://melanomaeducation.org.au/) (free registration required). SPEAKERS Prof Pascale Guitera Director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital | Professorial Research Fellow, The University of Sydney | Faculty Member, Melanoma Institute Australia Prof Rachael Morton Director of Health Economics and Health Technology Assessment, The Sydney Clinical Trials Centre, The University of Sydney | Faculty Member, Melanoma Institute Australia Prof Victoria Mar Director of the Victorian Melanoma Service at The Alfred | Professor of DermatoOncology, School of Public Health and Preventive Medicine, Monash University Dr Amelia Smit Senior Research Fellow in Cancer Epidemiology , The Daffodil Centre, The University of Sydney and Cancer Council NSW Please note that this podcast was accurate at the time of recording (September 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. MIA’s Education Program (https://melanomaeducation.org.au/) is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.

2. 

   17 Jul 2026

   From collaboration to innovation: How multidisciplinary teams and clinical trials are transforming melanoma care

   In this episode from MIA’s podcast Melanoma Insights for Professionals, our experts explore the critical role of multidisciplinary collaboration in delivering contemporary melanoma care. Hear how melanoma multidisciplinary teams (MDTs) bring together diverse expertise to navigate increasingly complex treatment pathways, discuss challenging cases and identify opportunities for patients to participate in clinical trials. The discussion provides insight into how MDTs operate in practice, the value they bring to patient outcomes, and how collaboration between clinicians and researchers continues to drive progress. The panel also explores why clinical trials remain fundamental to advancing melanoma care, how practice-changing evidence has shaped current standards of treatment, and what emerging developments may define the future of melanoma management. This podcast is suitable for multidisciplinary specialists, clinical trial researchers and other healthcare professionals. REFERENCE GV Long, et al. A phase 2 study of neoadjuvant nivolumab (nivo) + relatlimab (rela) in high-risk stage II cutaneous melanoma (NeoReNi). (https://ascopubs.org/doi/10.1200/JCO.2026.44.16_suppl.9502) J Clin Oncol 44, 9502-9502(2026). SPEAKERS Prof Alexander van Akkooi - Surgical Oncologist | Melanoma Institute Australia and The University of Sydney Prof Georgina Long AO - Medical Oncologist and Medical Director | Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital Maria Gonzalez - CEO and former Head of Clinical Trials | Melanoma Institute Australia Please note that this podcast was accurate at the time of recording (June 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. Melanoma Institute Australia’s Education Program⁠ (https://melanomaeducation.org.au/) is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.

3. 

   7 Jun 2026

   Redefining Immunotherapy (Ep. 5): Hype vs Reality: The Future of Immunotherapy

   In our final episode of our special vodcast series, RedefiningImmunotherapy: Lessons from Melanoma, our experts discuss the future of immunotherapy, separating hype from reality and exploring the next frontier of cancer treatment. From cellular therapies and personalised cancer vaccines tomRNA technology and biomarker-driven treatment selection, the panel examines the innovations that could reshape melanoma care over the next decade and the challenges that remain before these therapies become routine clinical practice. Led by Prof Georgina Long AO, the panel of experts discuss: why melanoma continues to lead the globalimmunotherapy revolution the promise and limitations of TIL therapy,TCR-T cells and other cellular therapies how mRNA technology could transform cancertreatment beyond vaccines the rise of personalised cancer vaccines why biomarkers will be critical to the future ofprecision immunotherapy. Be sure to take a look at our earlier episodes from this series. This special edition vodcast from ⁠Melanoma Institute Australia⁠ (https://melanoma.org.au/) is suitable for Medical Oncologists, Oncology Nurses and other health professionals. SPEAKERS Prof Georgina Long AO - Medical Oncologist, Melanoma Institute Australia and The University of Sydney Prof Alexander Menzies - Medical Oncologist, Melanoma Institute Australia and The University of Sydney A/Prof Ines Silva - Medical Oncologist, Melanoma Institute Australia A/Prof Matteo Carlino - Medical Oncologist, Melanoma Institute Australia and The University of Sydney Please note that this presentation was accurate at the time of recording (April 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. This special vodcast is an initiative of ⁠⁠Melanoma Institute Australia⁠⁠ (http://www.melanoma.org.au/) and made possible by an unrestricted educational grant from Bristol Myers Squibb. For more practise-changing education, visit MIA's ⁠⁠Melanoma Education Portal⁠⁠ (https://melanomaeducation.org.au/).

Who has been a guest on Melanoma Insights for Professionals

Names identified in recent episode analyses. Showing up to five guests.

• Alexander van Akkooi
• Robyn Saw
• Alexander Menzies
• Robert Rawson

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

4.3 / 5

4 ratings

Spotify

5.0 / 5

8 ratings

Podcast Authority Score: 34 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

55

Social presence

0

YouTube

0

Engagement

32

Contact Melanoma Insights for Professionals

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.